| pioglitazone / Generic mfg. |
NCT00232362: Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus |
|
|
| Withdrawn | 1 | 0 | US | Pioglitazone (Actos), Anti-diabetic agent other than pioglitazone or rosiglitazone | Texas Tech University Health Sciences Center | Type 2 Diabetes Mellitus | | 06/08 | | |
| Completed | 1 | 211 | US | Comparator: sitagliptin phosphate, Comparator: pioglitazone, Comparator: placebo to pioglitazone, Comparator: placebo to sitagliptin | Merck Sharp & Dohme LLC | Type 2 Diabetes Mellitus (T2DM) | 02/09 | 02/09 | | |
NCT01088594: A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers |
|
|
| Completed | 1 | 12 | Europe | pioglitazone/rosiglitazone/placebo, rosiglitazone/pioglitazone/placebo, placebo/pioglitazone/rosiglitazone, pioglitazone/placebo/rosiglitazone, rosiglitazone/placebo/pioglitazone, placebo/rosiglitazone/pioglitazone | Solvay Pharmaceuticals | Type 2 Diabetes Mellitus | 03/10 | 03/10 | | |
NCT01082120: Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus |
|
|
| Completed | 1 | 28 | US | AZD1656, Pioglitazone | AstraZeneca | Type 2 Diabetes Mellitus | 05/10 | 05/10 | | |
NCT01115712: Effects of Pioglitazone on Insulin Sensitivity in Healthy Overweight and Obese Males (MK-0000-170) |
|
|
| Completed | 1 | 35 | US | Placebo, Comparator: Pioglitazone, Comparator: Hyperinsulinemic Euglycemic Clamp | Merck Sharp & Dohme LLC | Healthy, Overweight, Obesity | 09/10 | 09/10 | | |
NCT00545857: Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus |
|
|
| Completed | 1 | 15 | US | pioglitazone, Actos, Placebo control | Stony Brook University | Type 1 Diabetes Mellitus | 05/12 | 05/12 | | |
|
